Termination of the oestrogen-alone arm of the Women's Health Initiative

J Br Menopause Soc. 2004 Jun;10(2):47, 59.
No abstract available

Publication types

  • News

MeSH terms

  • Aged
  • Cardiovascular Diseases / prevention & control
  • Estrogens, Conjugated (USP) / adverse effects*
  • Estrogens, Conjugated (USP) / therapeutic use
  • Female
  • Hormone Replacement Therapy / adverse effects*
  • Hormone Replacement Therapy / methods
  • Humans
  • Menopause / drug effects*
  • Middle Aged
  • Osteoporosis, Postmenopausal / prevention & control
  • Risk Assessment
  • United States
  • Women's Health*

Substances

  • Estrogens, Conjugated (USP)